1. Home
  2. OTLK vs WOK Comparison

OTLK vs WOK Comparison

Compare OTLK & WOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTLK
  • WOK
  • Stock Information
  • Founded
  • OTLK 2010
  • WOK 2002
  • Country
  • OTLK United States
  • WOK China
  • Employees
  • OTLK N/A
  • WOK N/A
  • Industry
  • OTLK Biotechnology: Biological Products (No Diagnostic Substances)
  • WOK
  • Sector
  • OTLK Health Care
  • WOK
  • Exchange
  • OTLK Nasdaq
  • WOK NYSE
  • Market Cap
  • OTLK 64.6M
  • WOK 70.3M
  • IPO Year
  • OTLK 2016
  • WOK 2024
  • Fundamental
  • Price
  • OTLK $1.83
  • WOK $2.29
  • Analyst Decision
  • OTLK Strong Buy
  • WOK
  • Analyst Count
  • OTLK 5
  • WOK 0
  • Target Price
  • OTLK $21.00
  • WOK N/A
  • AVG Volume (30 Days)
  • OTLK 892.5K
  • WOK 194.1K
  • Earning Date
  • OTLK 02-12-2025
  • WOK 02-03-2025
  • Dividend Yield
  • OTLK N/A
  • WOK N/A
  • EPS Growth
  • OTLK N/A
  • WOK N/A
  • EPS
  • OTLK N/A
  • WOK N/A
  • Revenue
  • OTLK N/A
  • WOK $9,863,642.00
  • Revenue This Year
  • OTLK N/A
  • WOK N/A
  • Revenue Next Year
  • OTLK $396.84
  • WOK N/A
  • P/E Ratio
  • OTLK N/A
  • WOK N/A
  • Revenue Growth
  • OTLK N/A
  • WOK N/A
  • 52 Week Low
  • OTLK $0.87
  • WOK $2.16
  • 52 Week High
  • OTLK $12.85
  • WOK $8.45
  • Technical
  • Relative Strength Index (RSI)
  • OTLK 39.18
  • WOK N/A
  • Support Level
  • OTLK $1.79
  • WOK N/A
  • Resistance Level
  • OTLK $2.26
  • WOK N/A
  • Average True Range (ATR)
  • OTLK 0.18
  • WOK 0.00
  • MACD
  • OTLK 0.00
  • WOK 0.00
  • Stochastic Oscillator
  • OTLK 6.09
  • WOK 0.00

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

About WOK WORK MEDICAL TECHNOLOGY GROUP LTD

WORK Medical Technology Group Ltd is a manufacturer of medical devices, and it is committed to providing professional and reliable medical devices to the world.

Share on Social Networks: